sr141716 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braida, D; Sala, M | 1 |
| Hunt, GE; Li, KM; Mallet, PE; McGregor, IS; Morley, KC | 1 |
| Braida, D; Iosuè, S; Pegorini, S; Sala, M | 1 |
| Maldonado, R; Touriño, C; Valverde, O | 1 |
| Aguilar, MA; Do Couto, BR; Manzanedo, C; Miñarro, J; Rodríguez-Arias, M; Roger-Sánchez, C | 1 |
| Aguilar, MA; Daza-Losada, M; Maldonado, C; Manzanedo, C; Miñarro, J; Rodríguez-Arias, M | 1 |
| Taffe, MA | 1 |
7 other study(ies) available for sr141716 and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabinoids; Conditioning, Operant; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Fatty Acids, Unsaturated; Hallucinogens; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement, Psychology; Rimonabant; Self Administration | 2002 |
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.
Topics: Animals; Cannabinoids; Cyclohexanols; Fever; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin | 2004 |
3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system.
Topics: Animals; Cannabinoid Receptor Modulators; Conditioning, Psychological; Dose-Response Relationship, Drug; Endocannabinoids; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |
MDMA attenuates THC withdrawal syndrome in mice.
Topics: Animals; Brain; Cannabinoid Receptor Antagonists; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rimonabant; Serotonin; Substance Withdrawal Syndrome | 2007 |
Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Hallucinogens; Male; Mice; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Naphthalenes; Piperidines; Pyrazoles; Reinforcement Schedule; Rimonabant; Spatial Behavior; Time Factors | 2010 |
Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
Topics: Animals; Behavior, Animal; Benzoxazines; Brain Chemistry; Calcium Channel Blockers; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Male; Mice; Mice, Inbred Strains; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Naphthalenes; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Serotonin Agents | 2010 |
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Body Temperature; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fever; Hallucinogens; Macaca mulatta; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rimonabant; Telemetry; Time Factors | 2012 |